Back to search

Article

Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling

2023-01-03

Abstract excerpt

Chemotherapy mistreatment is partially due to a lack of rapid and reliable tools to discriminate between sensitive and resistant phenotypes. In many cases, the resistance mechanism is not fully understood, impacting diagnostic tools' absence. This work aims to determine the capacity of MALDI-TOF-MS profiling to discriminate between chemotherapy-resistant and sensitive phenotypes in leukemia and glioblastoma cells....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3cbc911-ed24-5c18-b9d0-6c3740d93d93
DOI
10.21203/rs.3.rs-2406258/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profilingDOI 10.21203/rs.3.rs-2406258/v1
Discrimination of the chemotherapy resistance status of human leukemia and glioblastoma cell lines by MALDI-TOF-MS profiling.Semantic proximity
Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma CellsSemantic proximity
Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challengesSemantic proximity
Integrative Machine Learning Framework for Detecting Resistance-Associated Mutations in Cancer Cell LinesSemantic proximity
Integrative Machine Learning Framework for Detecting Resistance-Associated Mutations in Cancer Cell LinesSemantic proximity
Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancerSemantic proximity
Transgenomic's WAVE System used for the early detection of drug resistance mutations in chronic myeloid leukemia.Semantic proximity
DIA-based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid LeukemiaSemantic proximity
New Insights into Neuroblastoma Cisplatin Resistance: A Comparative Proteomic and Meta-Mining InvestigationSemantic proximity
Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics.Semantic proximity
Multi-omic profiling of tyrosine kinase inhibitor-resistant K562 cells suggests metabolic reprogramming to promote cell survivalSemantic proximity
Cell-Main Spectra Profile Screening Technique in Simulation of Circulating Tumour Cells Using MALDI-TOF Mass SpectrometrySemantic proximity
Select a neighboring publication to make it the new centre.